( en | de | ru )

 

Disambiguierung von "Parola, Philippe"

Autor der Publikation

KopierenLöschenDiese Publikation zur Ablage hinzufügen
Early Treatment with Hydroxychloroquine and Azithromycin in 10,429 COVID-19 Outpatients: A Monocentric Retrospective Cohort Study

, , , , , , , , , , , , , , , , , , , , , , , , , , , und . International Journal of Infectious Diseases, (2021)

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

Philippe Zysset

Philippe Dreuw

Philippe Moisan

Philippe Kersting

Philippe Bopp

 

Weitere Publikationen von Autoren mit dem selben Namen

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France, , , , , , , , , und 27 andere Autor(en). Travel Medicine and Infectious Disease, (2020)Epidemiology of relapsing fever borreliosis in Europe., und . FEMS Immunology & Medical Microbiology, 48 (1): 11--15 (Oktober 2006)Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study, , , , , , , , , und 19 andere Autor(en). Travel Medicine and Infectious Disease, (2020)This is the second Marseille study.Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France, , , , , , , , , und 27 andere Autor(en). Travel Medicine and Infectious Disease, (2020)Early Treatment with Hydroxychloroquine and Azithromycin in 10,429 COVID-19 Outpatients: A Monocentric Retrospective Cohort Study, , , , , , , , , und 18 andere Autor(en). International Journal of Infectious Diseases, (2021)Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to David Spencer (Elsevier), , , , , , und . (2020)Early treatment of 1061 COVID-19 patients with hydroxychloroquine and azithromycin, Marseille, France, , , , , , , , , und 27 andere Autor(en). (2020)Tick- and flea-borne rickettsial emerging zoonoses., , und . Veterinary Research, 36 (3): 469--492 (2005)Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, , , , , , , , , und 8 andere Autor(en). International Journal of Antimicrobial Agents, 56 (1): 105949 (2020)Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis, , , , , , , , , und 33 andere Autor(en). Travel Medicine and Infectious Disease, (2020)